METHODS FOR SOLUBLE ZALPHA11 CYTOKINE RECEPTORS
    16.
    发明申请
    METHODS FOR SOLUBLE ZALPHA11 CYTOKINE RECEPTORS 审中-公开
    可溶性ZALPHA11细胞因子受体的方法

    公开(公告)号:US20100074905A1

    公开(公告)日:2010-03-25

    申请号:US12560637

    申请日:2009-09-16

    摘要: Novel polypeptide combinations, polynucleotides encoding the polypeptides, and related compositions and methods are disclosed for soluble zalpha11 receptors that may be used as novel cytokine antagonists, and within methods for detecting ligands that stimulate the proliferation and/or development of hematopoietic, lymphoid and myeloid cells in vitro and in vivo. Ligand-binding receptor polypeptides can also be used to block zalpha11 Ligand activity in vitro and in vivo, and may be used in conjunction with zalpha11 Ligand and other cytokines to selectively stimulate the immune system. The present invention also includes methods for producing the protein, uses therefor and antibodies thereto.

    摘要翻译: 公开了可用作新型细胞因子拮抗剂的可溶性zalpha11受体的新型多肽组合,编码多肽的多核苷酸以及相关组合物和方法,以及用于检测刺激造血,淋巴和骨髓细胞增殖和/或发育的配体的方法 体外和体内。 配体结合受体多肽也可用于在体外和体内阻断zalpha11配体活性,并可与zalpha11配体和其他细胞因子结合使用以选择性刺激免疫系统。 本发明还包括生产蛋白质的方法,用途及其抗体。

    Four-helical bundle protein zsig81
    19.
    发明授权
    Four-helical bundle protein zsig81 失效
    四螺旋束蛋白zsig81

    公开(公告)号:US07223564B2

    公开(公告)日:2007-05-29

    申请号:US10315379

    申请日:2002-12-09

    CPC分类号: C07K14/47 C07K14/475

    摘要: This present invention is directed to polypeptide and polynucleotide molecules that encode a four-helical bundle cytokine. The cytokine has been designated zsig81, and has restricted expression in primarily heart, lung and liver. zsig81 has been shown to stimulate proliferation of hematopoietic cells and will be useful expansion of these cells, as well as conditions associated with hematopoietic cells. The invention is directed to antibodies and methods of making zsig81 polypeptides, as well.

    摘要翻译: 本发明涉及编码四螺旋束细胞因子的多肽和多核苷酸分子。 细胞因子被指定为zsig81,并且主要限制在心脏,肺和肝中的表达。 已经显示zsig81刺激造血细胞的增殖,并且这些细胞的有用扩张以及与造血细胞相关的病症。 本发明还涉及制备zsig81多肽的抗体和方法。